Due to wide media coverage, the demand for weight-loss drugs, semaglutide and tirzepatide, has increased worldwide among overweight and obese individuals. However, these drugs are not approved or available everywhere, including in India. Nevertheless, affluent Indians are approaching obesity specialists for weight-loss drug prescriptions. According to a doctor who is famous on Instagram, women aged between their 20s and early 50s predominantly visited her for semaglutide prescriptions.
While the majority of them are obese, some young patients visited her, seeking to lose weight faster. Although semaglutide or tirzepatide are not marketed in India for weight-loss treatment , pharmaceutical distributors import them from countries such as Belgium, Hong Kong, Bulgaria, Egypt, and UAE. While a month-supply of semaglutide costs US$936 in the USA, it is sold from Rs. 8,000 to 1.3 lakh in…
